Checkpoint Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights Aug 08, 2019
Avenue Therapeutics Announces Appointment of Ms. E. Garrett Ingram to Board of Directors Aug 01, 2019
Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Acute Myeloid Leukemia Jul 24, 2019
Avenue Therapeutics Announces Positive Topline Data from Second Pivotal Phase 3 Study of Intravenous Tramadol in the Management of Postoperative Pain Jun 03, 2019
Mustang Bio and St. Jude Children’s Research Hospital to Participate in Panel Discussion at Boston CEO 2019 May 23, 2019
Mustang Bio and Nationwide Children’s Hospital Receive Orphan Drug Designation for MB-108 (Oncolytic Virus C134) for the Treatment of Malignant Glioma May 16, 2019
Avenue Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights May 13, 2019
